Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
05/1999
05/14/1999WO1999023208A2 RIBOZYMES TARGETED TO IL-15 mRNA
05/14/1999WO1999023108A1 Inducible phosphofructokinase and the warburg effect
05/14/1999WO1999023097A1 Substituted porphyrins
05/14/1999WO1999023091A1 Aromatic heterocyclic compounds as anti-inflammatory agents
05/14/1999WO1999023087A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors
05/14/1999WO1999023076A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
05/14/1999WO1999022765A1 Control of lymphocyte localization by leep-cam activity
05/14/1999WO1999022761A1 Conjugate heat shock protein-binding peptides
05/14/1999WO1999022729A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
05/14/1999WO1999022716A1 Topical compositions for nsai drug delivery
05/14/1999WO1999007351A3 Indole derivatives and their use as mcp-1 antagonists
05/14/1999WO1999005269A8 Transcriptional silencer protein nrf
05/14/1999WO1999001467A3 Therapeutically active compounds with low systemic activity due to reduce half life
05/14/1999WO1998051289A3 Monoesters of probucol for the treatment of cardiovascular and inflammatory disease
05/14/1999WO1997035539A3 Arylamino fused pyridines and pyrimidines
05/14/1999CA2309175A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
05/14/1999CA2308428A1 Aromatic heterocyclic compounds as anti-inflammatory agents
05/14/1999CA2308299A1 Conjugate heat shock protein-binding peptides
05/14/1999CA2308091A1 Inducible phosphofructokinase and the warburg effect
05/14/1999CA2308018A1 Ribozymes targeted to il-15 mrna
05/14/1999CA2307853A1 Diaryl-5-alkyl-5-methyl-2(5h)-furanones as selective cyclooxygenase-2 inhibitors
05/12/1999EP0915086A1 Phenylsulfonamide derivatives
05/12/1999EP0914605A1 Molecular model for vla-4 inhibitors
05/12/1999EP0914459A2 Adenoviral mediated gene transfer in adipocytes and related implants
05/12/1999EP0914456A1 Gene expression in monocytes and macrophages
05/12/1999EP0914432A2 Secreted proteins and polynucleotides encoding them
05/12/1999EP0914430A2 Polynucleotides from human fetal brain encoding secreted proteins
05/12/1999EP0914345A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2)
05/12/1999EP0914333A1 Peptide derivatives
05/12/1999EP0914330A1 Novel compounds
05/12/1999EP0914322A1 New indolyl and benzofuranyl carboxamides as inhibitors of nitric oxide production
05/12/1999EP0914319A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
05/12/1999EP0914129A1 Use of aspirochlorine or derivatives thereof as immunosuppressive agents
05/12/1999EP0592553B1 Pla2 inhibitory compounds
05/11/1999US5902824 Phenyldihydrobenzofuranes
05/11/1999US5902810 Pteridine derivatives as no synthase inhibitors
05/11/1999US5902803 5H,10H-imidazo 1,2-a!indeno 1,2-e!pyrazin-4-one derivatives, preparation thereof, and drugs containing said derivatives
05/11/1999US5902800 Dextran formulations and method for treatment of inflammatory joint disorders
05/11/1999US5902796 Bioactive factors of aloe vera plants
05/11/1999US5902791 Metalloproteinase inhibitors
05/11/1999CA2122724C Fusion proteins comprising mgf and il-3
05/06/1999WO1999022243A1 148 human secreted proteins
05/06/1999WO1999021860A1 Phenanthroline derivatives
05/06/1999WO1999021834A1 Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors
05/06/1999WO1999021824A1 Cyclic amino acids and derivatives thereof useful as pharmaceutical agents
05/06/1999WO1999021617A2 Allosteric adenosine receptor modulators
05/06/1999WO1999021559A1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS
05/06/1999WO1999021546A1 N,N-DIETHYLGLYCOLAMIDO ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS
05/06/1999WO1999015493A8 9,10-dihydro-9,10-ethanoanthracene derivatives as phospholipase inhibitors
05/06/1999WO1999008729A9 Loading and release of water-insoluble drugs
05/06/1999EP0913476A2 Ornithine carbamoyl transferase sequence and uses thereof
05/06/1999EP0912747A1 Aspartic protease
05/06/1999EP0912741A2 T-cell selective interleukin-4 agonists
05/06/1999EP0912740A1 Rantes homolog from prostate
05/06/1999EP0912731A2 Secreted proteins
05/06/1999EP0912730A2 Conjugates of soluble peptidic compounds with membrane-binding agents
05/06/1999EP0912578A1 3-ureido-pyridofurans and -pyridothiophenes for the treatment of inflammatory processes
05/06/1999EP0912575A1 Improved methods for the synthesis of chemical compounds having pde-iv inhibitory activity
05/06/1999EP0912571A2 Naphthyridines which affect il-4 and g-csf
05/06/1999EP0912558A1 Substituted indazole derivatives and their use as phosphodiesterase (pde) type iv and tumor necrosis factor (tnf) inhibitors
05/06/1999EP0912545A1 Hydroxamic acid based collagenase inhibitors
05/06/1999EP0912521A1 Substituted indazole derivatives and their use as inhibitors phosphodiesterase (pde) type iv and the production of tumor necrosis factor (tnf)
05/06/1999EP0912518A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors
05/06/1999EP0912505A1 Il-8 receptor antagonists
05/06/1999EP0912496A1 Inhibition of matrix metalloproteases by acetylene containing compounds
05/06/1999EP0912487A1 Substituted oxobutyric acids as matrix metalloprotease inhibitors
05/06/1999EP0912193A1 Vaccine to prevent streptococcal endocarditis
05/06/1999EP0912185A1 Novel pharmaceutical compositions having steroid nitrate ester derivatives useful as anti-inflammatory drugs
05/06/1999EP0912184A1 Use of k-252a derivative for the treatment of peripheral or central nerve disorders, and cytokine overproduction
05/06/1999EP0750607B1 2-(aminoalkoxy)phenylalkylamines with antiinflammatory activity
05/06/1999EP0667911B1 Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase
05/06/1999CA2309135A1 N,n-diethylglycolamido ester prodrugs of indole spla2 inhibitors
05/06/1999CA2308443A1 Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors
05/06/1999CA2307830A1 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
05/06/1999CA2307320A1 148 human secreted proteins
05/05/1999CN1216043A Substd. benzenesulfonamide derivs as prodrugs of COX-2 inhibitors
05/05/1999CN1215990A IL-8 receptor antagonists
05/05/1999CN1215989A Dosage form of ibuprofen
05/04/1999US5900434 Method for inhibiting the production of interleukin-1 or tumor necrosis factor-α by administering acanthoic acid
05/04/1999US5900257 Cosmetic/pharmaceutical compositions comprising lanthanide manganese, tin and/or yttrium salts as substance P antagonists
05/04/1999US5900247 Mucoadhesive pharmaceutical composition for the controlled release of active principles
05/04/1999US5900231 Cosmetic and/or dermatological skin treatment
05/04/1999CA2184604C Bicyclic carbamates
05/04/1999CA2137001C Lipids for epidermal moisturization and repair of barrier function
05/04/1999CA2129637C Treatment for inflammatory bowel disease
05/04/1999CA2074641C Method of treating ocular inflammation
05/04/1999CA2063689C Ibuprofen lysinate pharmaceutical formulation
05/04/1999CA1340529C Pediatric ibuprofen compositions
04/1999
04/30/1999CA2248996A1 Novel ornithine carbamoyltransferase
04/30/1999CA2219867A1 The use of proteasome inhibitors for treating cancer, inflammation, autoimmune disease, graft rejection and septic shock
04/29/1999WO1999020759A1 Chemokines with amino-terminal modifications
04/29/1999WO1999020653A1 Low-toxicity human interferon-alpha analog
04/29/1999WO1999020646A1 Estra-1,3,5(10)-triene-7alpha-thioethers
04/29/1999WO1999020624A1 Bicyclic kinase inhibitors
04/29/1999WO1999020608A1 Isoquinolines as urokinase inhibitors
04/29/1999WO1999020601A1 α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
04/29/1999WO1999020310A1 J-chain and analogues as epithelial cell targeting conjugates
04/29/1999WO1999020268A1 (3r,4r)-δ-tetrahydrocannabinol-11-oic acids useful as antiinflammatory agents and analgesics
04/29/1999WO1999007401A3 The use of erythropoietin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases
04/29/1999WO1999006070A9 Switchable viscoelastic systems containing galactomannan polymers and borate
1 ... 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 ... 1272